The last year has kept some Spanish Courts busy with a debate that already caught the attention of English Courts at the beginning of the XX century, that is, whether “omnibus” claims are enforceable. Article 100 of the “Estatuto de la Propiedad Industrial” of 1929 required that the last claim of the patent was an…
In a decision of 7 September 2010, the Dutch Patent Office (NL Octrooicentrum) on appeal confirmed its earlier decision to not grant a supplementary protection certificate (SPC) for the medicinal product tocilizumab, a humanized monoclonal antibody against the human interleukin-6 receptor, which is approved as a human rheumatoid arthritis drug. The applicant had requested an…
In July 2010, the European Commission published a press release on its findings in the Report on the monitoring of patent settlements (Press release IP/10/887). Sparked by this survey, we have conducted an informal investigation into patent settlements in Denmark during the period January 2000 until January 2010, which shows that during this period in…
By Legislative Decree no. 131 of 13 August 2010, which became effective on 2 September 2010, the Italian legislator passed a number of amendments to the Italian IP Code. One of these is new Art. 68 (1bis) on the statutory limitations to patent rights (which in paragraph 1 already included, and still includes, personal use,…
On 1 October 2010 the Patents County Court is due to be re-launched with a new set of procedural rules. The aim of the reforms is to provide a cheaper and quicker forum than the High Court for litigating relatively straightforward and low-value IP disputes. Hand-in-hand with the changes in procedure comes the appointment of…
In the 30 June 2010 decision, the Cour d’Appel of Paris stated how the novelty of an invention, namely a pharmaceutical compound having a high degree of purity, should be assessed.
In my first post I have described the old shabby courtroom of the patent chamber of the District Court of Düsseldorf. Meanwhile the court has moved to a new court house which is situated close to the central station. This new location is the result of a more service oriented approach of the judicature. Not…
On 12 July 2010 the Supreme Court handed down a long-waited judgment, dismissing a complaint filed by a manufacturer of generic medicaments against a patent owner that had threatened more than one hundred wholesalers with patent infringement actions. The facts of the case go back to 2003, when a Court of First Instance of Madrid…
By decision of 29 July 2010, the Italian Supreme Administrative Court (Consiglio di Stato) tackled the difficult issue of whether the Italian drugs regulatory authority (Agenzia Italiana del Farmaco – AIFA) should or should not consider the existence of a patent when adopting decisions relating to the marketing authorisations of generics. In the case at…
Under the UK’s standard duty of disclosure, each party is required to disclose the documents on which it relies, the documents which adversely affect its or another party’s case and the documents which support another party’s case. In patent disputes, disclosure relating to infringement of a product or process can be avoided by the provision…
